These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Alteration in NFKBIA and EGFR in glioblastoma multiforme. Komotar RJ; Starke RM; Connolly ES; Sisti MB Neurosurgery; 2011 Jun; 68(6):N14-5. PubMed ID: 21778941 [No Abstract] [Full Text] [Related]
4. Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas. Yadav AK; Renfrow JJ; Scholtens DM; Xie H; Duran GE; Bredel C; Vogel H; Chandler JP; Chakravarti A; Robe PA; Das S; Scheck AC; Kessler JA; Soares MB; Sikic BI; Harsh GR; Bredel M JAMA; 2009 Jul; 302(3):276-89. PubMed ID: 19602687 [TBL] [Abstract][Full Text] [Related]
5. New pattern of EGFR amplification in glioblastoma and the relationship of gene copy number with gene expression profile. Lopez-Gines C; Gil-Benso R; Ferrer-Luna R; Benito R; Serna E; Gonzalez-Darder J; Quilis V; Monleon D; Celda B; Cerdá-Nicolas M Mod Pathol; 2010 Jun; 23(6):856-65. PubMed ID: 20305620 [TBL] [Abstract][Full Text] [Related]
6. Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients. Figueroa JM; Skog J; Akers J; Li H; Komotar R; Jensen R; Ringel F; Yang I; Kalkanis S; Thompson R; LoGuidice L; Berghoff E; Parsa A; Liau L; Curry W; Cahill D; Bettegowda C; Lang FF; Chiocca EA; Henson J; Kim R; Breakefield X; Chen C; Messer K; Hochberg F; Carter BS Neuro Oncol; 2017 Oct; 19(11):1494-1502. PubMed ID: 28453784 [TBL] [Abstract][Full Text] [Related]
7. miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme. Yin D; Ogawa S; Kawamata N; Leiter A; Ham M; Li D; Doan NB; Said JW; Black KL; Phillip Koeffler H Oncogene; 2013 Feb; 32(9):1155-63. PubMed ID: 22580610 [TBL] [Abstract][Full Text] [Related]
8. Copy Number Profiling of Brazilian Astrocytomas. Bidinotto LT; Torrieri R; Mackay A; Almeida GC; Viana-Pereira M; Cruvinel-Carloni A; Spina ML; Campanella NC; Pereira de Menezes W; Clara CA; Becker AP; Jones C; Reis RM G3 (Bethesda); 2016 Jul; 6(7):1867-78. PubMed ID: 27172220 [TBL] [Abstract][Full Text] [Related]
9. Correlation between EGFR amplification and the expression of microRNA-200c in primary glioblastoma multiforme. Serna E; Lopez-Gines C; Monleon D; Muñoz-Hidalgo L; Callaghan RC; Gil-Benso R; Martinetto H; Gregori-Romero A; Gonzalez-Darder J; Cerda-Nicolas M PLoS One; 2014; 9(7):e102927. PubMed ID: 25058589 [TBL] [Abstract][Full Text] [Related]
10. Identification of a NFKBIA polymorphism associated with lower NFKBIA protein levels and poor survival outcomes in patients with glioblastoma multiforme. Zhao Z; Zhong X; Wu T; Yang T; Chen G; Xie X; Wei Y; Ye M; Zhou Y; Du Z Int J Mol Med; 2014 Nov; 34(5):1233-40. PubMed ID: 25215581 [TBL] [Abstract][Full Text] [Related]
11. NFKBIA deletion in glioblastomas. Idbaih A; Marie Y; Sanson M N Engl J Med; 2011 Jul; 365(3):277; author reply 277-8. PubMed ID: 21774727 [No Abstract] [Full Text] [Related]
12. Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas. van den Bent MJ; Gao Y; Kerkhof M; Kros JM; Gorlia T; van Zwieten K; Prince J; van Duinen S; Sillevis Smitt PA; Taphoorn M; French PJ Neuro Oncol; 2015 Jul; 17(7):935-41. PubMed ID: 25691693 [TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates. Kastenhuber ER; Huse JT; Berman SH; Pedraza A; Zhang J; Suehara Y; Viale A; Cavatore M; Heguy A; Szerlip N; Ladanyi M; Brennan CW Acta Neuropathol; 2014 May; 127(5):747-59. PubMed ID: 24292886 [TBL] [Abstract][Full Text] [Related]
14. Paradoxical relationship between the degree of EGFR amplification and outcome in glioblastomas. Hobbs J; Nikiforova MN; Fardo DW; Bortoluzzi S; Cieply K; Hamilton RL; Horbinski C Am J Surg Pathol; 2012 Aug; 36(8):1186-93. PubMed ID: 22472960 [TBL] [Abstract][Full Text] [Related]
15. Pediatric glioblastomas: a histopathological and molecular genetic study. Suri V; Das P; Pathak P; Jain A; Sharma MC; Borkar SA; Suri A; Gupta D; Sarkar C Neuro Oncol; 2009 Jun; 11(3):274-80. PubMed ID: 18981259 [TBL] [Abstract][Full Text] [Related]
16. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens. Feldkamp MM; Lala P; Lau N; Roncari L; Guha A Neurosurgery; 1999 Dec; 45(6):1442-53. PubMed ID: 10598712 [TBL] [Abstract][Full Text] [Related]
17. Amplification and overexpression of epidermal growth factor receptor gene in glioblastomas of Chinese patients correlates with patient's age but not with tumor's clinicopathological pathway. Xie D; Zeng YX; Wang HJ; Tai LS; Wen JM; Tao Y; Ma NF; Hu L; Sham JS; Guan XY Acta Neuropathol; 2005 Nov; 110(5):481-9. PubMed ID: 16151725 [TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors. Cheng Y; Ng HK; Ding M; Zhang SF; Pang JC; Lo KW J Neuropathol Exp Neurol; 1999 Feb; 58(2):120-8. PubMed ID: 10029095 [TBL] [Abstract][Full Text] [Related]
19. Genetic Alterations of Epidermal Growth Factor Receptor in Glioblastoma: The Usefulness of Immunohistochemistry. Lee M; Kang SY; Suh YL Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):589-598. PubMed ID: 29912767 [TBL] [Abstract][Full Text] [Related]
20. Deletion and low expression of NFKBIA are associated with poor prognosis in lower-grade glioma patients. Kinker GS; Thomas AM; Carvalho VJ; Lima FP; Fujita A Sci Rep; 2016 Apr; 6():24160. PubMed ID: 27052952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]